Cargando…

Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway

Hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) are the main water-soluble compounds in Carthamus tinctorius L. However, studies on the effect of AHSYB on cerebral ischemia/reperfusion (I/R) injury and the therapeutic effect of HSYA by regulating silent information regulator 1 (SI...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangma, Yijia, Zhou, Huifen, Shao, Chongyu, Yu, Li, Yang, Jiehong, Wan, Haitong, He, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514692/
https://www.ncbi.nlm.nih.gov/pubmed/34658877
http://dx.doi.org/10.3389/fphar.2021.739864
_version_ 1784583447987093504
author Fangma, Yijia
Zhou, Huifen
Shao, Chongyu
Yu, Li
Yang, Jiehong
Wan, Haitong
He, Yu
author_facet Fangma, Yijia
Zhou, Huifen
Shao, Chongyu
Yu, Li
Yang, Jiehong
Wan, Haitong
He, Yu
author_sort Fangma, Yijia
collection PubMed
description Hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) are the main water-soluble compounds in Carthamus tinctorius L. However, studies on the effect of AHSYB on cerebral ischemia/reperfusion (I/R) injury and the therapeutic effect of HSYA by regulating silent information regulator 1 (SIRT1) pathway remain obscure. In this study, we investigated whether the neuroprotective effects of HSYA and AHSYB on oxygen-glucose deprivation/reoxygenation in primary-cultured hippocampal neuronal cells and the middle cerebral artery occlusion and reperfusion model in rats are associated with the regulation of the SIRT1 pathway. In vitro, HSYA and AHSYB increased cell viability, depressed oxidation properties, and reduced neuronal cell apoptosis. In vivo results showed that HSYA and AHSYB effectively reduced infarct volume, improved neurological function, suppressed apoptosis, and decreased the oxidative stress reaction. Besides, RT-PCR and Western blot analysis showed that HSYA and AHSYB increased the mRNA and protein expressions of the main factors in the SIRT1 pathway, including SIRT1, forkhead box O (FOXO) 1, and peroxisome proliferator–activated receptor coactivator 1α (PGC1α), decreased the expression of Bax, and increased the expression of Bcl-2. The results from immunohistochemistry also showed that the expressions of SIRT1, FOXO1, and PGC1α were increased after treatment with HSYA and AHSYB. Furthermore, the neuroprotective effects of HSYA and AHSYB were abolished by EX527 (SIRT1–specific inhibitor). These results indicated that HSYA and AHSYB should be developed into potential drugs for treating cerebral I/R injury via the SIRT1 pathway. Although HSYA and AHSYB have different chemical structures, both of them exert similar neuroprotective properties against I/R injury in vitro and in vivo, which means that AHSYB is also a non-negligible component in safflower.
format Online
Article
Text
id pubmed-8514692
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85146922021-10-15 Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway Fangma, Yijia Zhou, Huifen Shao, Chongyu Yu, Li Yang, Jiehong Wan, Haitong He, Yu Front Pharmacol Pharmacology Hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) are the main water-soluble compounds in Carthamus tinctorius L. However, studies on the effect of AHSYB on cerebral ischemia/reperfusion (I/R) injury and the therapeutic effect of HSYA by regulating silent information regulator 1 (SIRT1) pathway remain obscure. In this study, we investigated whether the neuroprotective effects of HSYA and AHSYB on oxygen-glucose deprivation/reoxygenation in primary-cultured hippocampal neuronal cells and the middle cerebral artery occlusion and reperfusion model in rats are associated with the regulation of the SIRT1 pathway. In vitro, HSYA and AHSYB increased cell viability, depressed oxidation properties, and reduced neuronal cell apoptosis. In vivo results showed that HSYA and AHSYB effectively reduced infarct volume, improved neurological function, suppressed apoptosis, and decreased the oxidative stress reaction. Besides, RT-PCR and Western blot analysis showed that HSYA and AHSYB increased the mRNA and protein expressions of the main factors in the SIRT1 pathway, including SIRT1, forkhead box O (FOXO) 1, and peroxisome proliferator–activated receptor coactivator 1α (PGC1α), decreased the expression of Bax, and increased the expression of Bcl-2. The results from immunohistochemistry also showed that the expressions of SIRT1, FOXO1, and PGC1α were increased after treatment with HSYA and AHSYB. Furthermore, the neuroprotective effects of HSYA and AHSYB were abolished by EX527 (SIRT1–specific inhibitor). These results indicated that HSYA and AHSYB should be developed into potential drugs for treating cerebral I/R injury via the SIRT1 pathway. Although HSYA and AHSYB have different chemical structures, both of them exert similar neuroprotective properties against I/R injury in vitro and in vivo, which means that AHSYB is also a non-negligible component in safflower. Frontiers Media S.A. 2021-09-30 /pmc/articles/PMC8514692/ /pubmed/34658877 http://dx.doi.org/10.3389/fphar.2021.739864 Text en Copyright © 2021 Fangma, Zhou, Shao, Yu, Yang, Wan and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fangma, Yijia
Zhou, Huifen
Shao, Chongyu
Yu, Li
Yang, Jiehong
Wan, Haitong
He, Yu
Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title_full Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title_fullStr Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title_full_unstemmed Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title_short Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway
title_sort hydroxysafflor yellow a and anhydrosafflor yellow b protect against cerebral ischemia/reperfusion injury by attenuating oxidative stress and apoptosis via the silent information regulator 1 signaling pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514692/
https://www.ncbi.nlm.nih.gov/pubmed/34658877
http://dx.doi.org/10.3389/fphar.2021.739864
work_keys_str_mv AT fangmayijia hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT zhouhuifen hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT shaochongyu hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT yuli hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT yangjiehong hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT wanhaitong hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway
AT heyu hydroxysaffloryellowaandanhydrosaffloryellowbprotectagainstcerebralischemiareperfusioninjurybyattenuatingoxidativestressandapoptosisviathesilentinformationregulator1signalingpathway